D. Wood

发表

The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose

P. Dargan, D. Wood, L. Hunter, 2011, Open access emergency medicine : OAEM.

The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose

P. Dargan, L. Hunter, D. Wood, 2011 .

Extracorporeal Treatment for Methotrexate Poisoning

R. Hoffman, T. Nolin, D. Goldfarb, 2022, Clinical journal of the American Society of Nephrology : CJASN.

Heavy metal poisoning from Ayurvedic traditional medicines: an emerging problem?

P. Dargan, I. Gawarammana, D. Shaw, 2008 .

Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction

P. Dargan, R. Hoffman, D. Wood, 2009, Clinical toxicology.

Is cocaine use recognised as a risk factor for acute coronary syndrome by doctors in the UK?

P. Dargan, S. Greene, D. Wood, 2007, Postgraduate Medical Journal.

Presentations to the Emergency Department Following Cannabis use—a Multi-Centre Case Series from Ten European Countries

P. Dargan, M. Galicia, D. Wood, 2015, Journal of Medical Toxicology.

Emergency department presentations with suspected acute coronary syndrome – frequency of self-reported cocaine use

P. Dargan, S. Greene, D. Wood, 2010, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective.

P. Dargan, D. Wood, D. Wood, 2010, British journal of clinical pharmacology.

Limited evidence for the safety of β-blockers for cocaine-associated chest pain.

W. L. Chan, P. Dargan, D. Wood, 2013, The American journal of emergency medicine.

Systematic review on the use of activated charcoal for gastrointestinal decontamination following acute oral overdose

W. L. Chan, R. Hoffman, Silas W Smith, 2021, Clinical toxicology.

Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study

P. Dargan, M. Liechti, A. Ceschi, 2023, Journal of clinical medicine.

An assessment of the variation in the concentration of acetylcysteine in infusions for the treatment of paracetamol overdose

P. Dargan, R. Flanagan, D. Wood, 2017, British journal of clinical pharmacology.

Understanding lactic acidosis in paracetamol (acetaminophen) poisoning.

P. Dargan, A. Shah, D. Wood, 2011, British journal of clinical pharmacology.

Measuring plasma salicylate concentrations in all patients with drug overdose or altered consciousness: is it necessary?

P. Dargan, D. Wood, A. Jones, 2005, Emergency Medicine Journal.

Status epilepticus following intentional overdose of fluvoxamine: A case report with serum fluvoxamine concentration*

P. Dargan, P. Morgan, Y. Rajalingam, 2007, Clinical toxicology.

First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201

P. Dargan, S. Hudson, D. Wood, 2012, European Journal of Clinical Pharmacology.

Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup

R. Hoffman, T. Nolin, D. Goldfarb, 2023, Critical Care.

Challenges in the diagnosis of ethylene glycol poisoning

P. Dargan, D. Wood, D. McQuade, 2014, Annals of clinical biochemistry.

Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act

P. Dargan, N. Webb, S. Greene, 2018, Clinical toxicology.

Ketamine—Epidemiology of misuse and patterns of acute and chronic toxicity

P. Dargan, D. Wood, Shwetha Rao, 2015 .

The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use

P. Dargan, D. Wood, S. S. Kalsi, 2011, Emerging health threats journal.

Chapter 12 – Ketamine

P. Dargan, D. Yew, J. Rudd, 2013 .

The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).

P. Dargan, D. Wood, R. Sedefov, 2011, Drug testing and analysis.

Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products.

J. Ramsey, P. Dargan, L. King, 2010, Journal of analytical toxicology.

Acute toxicity related to misuse (nonmedical use) of tramadol: Experience of the European Drug Emergencies Network Plus

P. Dargan, D. Wood, K. Layne, 2020, British journal of clinical pharmacology.

First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam

P. Dargan, Malgorzata Puchnarewicz, Susannah Davies, 2012, European Journal of Clinical Pharmacology.

Poisoned patients as potential organ donors: postal survey of transplant centres and intensive care units

P. Dargan, D. Wood, A. Jones, 2003, Critical care.

Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances)

J. Ramsey, P. Dargan, D. Wood, 2012, European Journal of Clinical Pharmacology.

Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: The recent United Kingdom experience

P. Dargan, J. Dear, A. Gray, 2014, Clinical toxicology.

Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment

D. Webb, P. Dargan, J. Dear, 2014, British journal of clinical pharmacology.

Paracetamol toxicity: what would be the implications of a change in UK treatment guidelines?

P. Dargan, D. Wood, D. McQuade, 2012, European Journal of Clinical Pharmacology.

Novel psychoactive substances: types, mechanisms of action, and effects

D. Tracy, D. Baumeister, D. Wood, 2017, British Medical Journal.

The toxicity of the novel psychoactive substances

P. Dargan, D. Wood, D. Wood, 2016 .

Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM

P. Dargan, D. Wood, L. Hunter, 2014, Postgraduate Medical Journal.

Novel psychoactive substances or 'legal highs'.

P. Dargan, D. Wood, K. Bonnici, 2015, British journal of hospital medicine.

Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP)

P. Dargan, D. Wood, D. Wood, 2012, Clinical toxicology.

Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP)

J. Ramsey, P. Dargan, D. Holt, 2008, Journal of Medical Toxicology.

Collapse, reported seizure—and an unexpected pill

J. Ramsey, P. Dargan, D. Holt, 2007, The Lancet.

Rhabdomyolysis related to acute recreational drug toxicity—A Euro-DEN study

P. Dargan, P. Kabata, D. Wood, 2021, PloS one.

New psychoactive substances: a review and updates

H. Sumnall, D. Tracy, A. Berry, 2020, Therapeutic advances in psychopharmacology.

Synthetic opioids: a review and clinical update

H. Sumnall, D. Tracy, A. Berry, 2022, Therapeutic advances in psychopharmacology.

2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death

P. Dargan, Paul I. Dargan, David M. Wood, 2011, Journal of Medical Toxicology.

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

R. Hoffman, T. Nolin, D. Goldfarb, 2021, Critical Care.

Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?

P. Dargan, W. Waring, D. Wood, 2011, Open access emergency medicine : OAEM.

Recreational drug use presentations during a large outdoor festival event: Reduction in hospital emergency department transfer where medical physicians are present

P. Dargan, D. Wood, Dan May, 2010 .

Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances—Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam—in the UK

P. Dargan, Thea Gilks, D. Wood, 2018, Journal of Medical Toxicology.

Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity.

P. Dargan, D. Owen, D. Wood, 2016, Drug and alcohol review.

Recreational Use of Mephedrone (4-Methylmethcathinone, 4-MMC) with Associated Sympathomimetic Toxicity

David W. Holt, John Ramsey, J. Ramsey, 2010, Journal of Medical Toxicology.

Should computerised tomography replace endoscopy in the evaluation of symptomatic ingestion of corrosive substances?

P. Dargan, D. Wood, K. Bonnici, 2014, Clinical toxicology.

Gut decontamination of acutely poisoned patients: what do doctors really know about it?

P. Dargan, S. Greene, D. Wood, 2007, Emergency Medicine Journal.

Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity

P. Dargan, D. Wood, D. Wood, 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.

P. Dargan, D. Wood, S. Albert, 2010, QJM : monthly journal of the Association of Physicians.

The rise in legal highs: prevalence and patterns in the use of illegal drugs and first- and second-generation “legal highs” in South London gay dance clubs

P. Dargan, F. Measham, K. Moore, 2011 .

Purchasing 'legal highs' on the Internet--is there consistency in what you get?

J. Ramsey, P. Dargan, D. Holt, 2010, QJM : monthly journal of the Association of Physicians.

Online availability of gabapentin and pregabalin and the impact of legal reclassification in the United Kingdom

P. Dargan, J. Hockenhull, D. Wood, 2022, Drugs: Education, Prevention and Policy.

The Availability of Modafinil and Methylphenidate Purchased from the Internet in the United Kingdom Without a Prescription

P. Dargan, J. Hockenhull, D. Wood, 2020, Substance use & misuse.

Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability

P. Dargan, C. Floyd, D. Wood, 2017, European Journal of Clinical Pharmacology.

Availability of prescription zopiclone over the internet

P. Dargan, D. Wood, James H. Ho, 2015, BMJ : British Medical Journal.

Pharmacology and toxicology of the synthetic cannabinoid receptor agonists

P. Dargan, D. Wood, C. Lovett, 2015 .

Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance

P. Dargan, D. Wood, James H. Ho, 2015, European Journal of Clinical Pharmacology.

4‐Methyl‐5‐(4‐methylphenyl)‐4,5‐dihydrooxazol‐2‐amine (4,4′‐DMAR, 4,4′‐dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity

P. Dargan, D. Wood, J. Glanville, 2015, Human psychopharmacology.

Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45

P. Dargan, D. Wood, Charlotte Verney, 2015, Clinical toxicology.

Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance 4-Methylaminorex and 4,4′-Dimethylaminorex

P. Dargan, D. Wood, H. Nizar, 2014, Journal of Medical Toxicology.

Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance Alpha-methyltryptamine (AMT)

P. Dargan, D. Wood, D. Wood, 2014, Substance use & misuse.

Pharmacology and Toxicology of the Synthetic Cannabinoid Receptor Agonists Pharmacologie et toxicologie des agonistes synthétiques des récepteurs cannabinoïdes

P. Dargan, D. Wood, C. Lovett, 2015 .

Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019

Ò. Miró, P. Dargan, M. Liechti, 2022, Clinical toxicology.

Synthetic Cannabinoid Receptor Agonists

P. Dargan, V. Auwärter, D. Wood, 2013 .

Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN)

P. Dargan, D. Wood, C. Yates, 2015, Clinical toxicology.

Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuse

P. Dargan, D. Wood, D. Wood, 2020, British journal of clinical pharmacology.

Nonmedical use of benzodiazepines and Z‐drugs in the UK

Colleen M Haynes, P. Dargan, R. Dart, 2020, British journal of clinical pharmacology.

Psychosis associated with acute recreational drug toxicity: a European case series

P. Dargan, D. Wood, C. Yates, 2016, BMC Psychiatry.

Prevalence of use and acute toxicity associated with the use of NBOMe drugs

P. Dargan, R. Sedefov, A. Cunningham, 2015, Clinical toxicology.

Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).

J. Ramsey, P. Dargan, D. Holt, 2007, QJM : monthly journal of the Association of Physicians.

Misuse of prescription medicines is as prevalent as the use of recreational drugs and novel psychoactive substances in Singapore: an unrecognised public health issue?

W. L. Chan, Colleen M Haynes, P. Dargan, 2020, Singapore medical journal.

Patient knowledge of the paracetamol content of over-the-counter (OTC) analgesics, cough/cold remedies and prescription medications

P. Dargan, D. Wood, E. English, 2010, Emergency Medicine Journal.

Recreational Drug Use in the Asia Pacific Region: Improvement in Our Understanding of the Problem Through the UNODC Programmes

P. Dargan, D. Wood, D. Wood, 2012, Journal of Medical Toxicology.

Novel psychoactive substances: identifying and managing acute and chronic harmful use

D. Tracy, D. Baumeister, D. Wood, 2017, British Medical Journal.

Epidemiology of adolescent substance use in London schools.

P. Dargan, I. Norman, J. Penney, 2016, QJM : monthly journal of the Association of Physicians.

Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation? The relationship between Mephedrone, Ecstasy and Cocaine

P. Dargan, F. Measham, K. Moore, 2013, European Addiction Research.

‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control

P. Dargan, F. Measham, D. Wood, 2012 .

Case series of individuals with analytically confirmed acute mephedrone toxicity

David W. Holt, John Ramsey, J. Ramsey, 2010, Clinical toxicology.

Impact of pregabalin co-use in patients presenting with acute heroin toxicity to the European Drug Emergencies Network Plus project.

P. Dargan, D. Wood, K. Hovda, 2021, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK.

P. Dargan, M. Le Lait, Jody L. Green, 2014, British journal of clinical pharmacology.

Gadolinium Concentrations in Biological Matrices From Patients Exposed to Gadolinium-Based Contrast Agents

P. Dargan, K. Raja, D. Wood, 2021, Investigative radiology.

Gadolinium-based contrast agents – what is the evidence for ‘gadolinium deposition disease’ and the use of chelation therapy?

P. Dargan, D. Wood, K. Layne, 2019, Clinical toxicology.

Gadolinium deposition and the potential for toxicological sequelae – A literature review of issues surrounding gadolinium‐based contrast agents

P. Dargan, D. Wood, K. Layne, 2018, British journal of clinical pharmacology.

Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose

D. Webb, P. Dargan, J. Dear, 2019, EClinicalMedicine.

Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a review.

P. Dargan, D. Wood, L. Hunter, 2011, British journal of clinical pharmacology.

What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient?

P. Dargan, D. Wood, J. Archer, 2015, Clinical toxicology.

Prescription medicine misuse in the Asia–Pacific region: An evolving issue?

W. L. Chan, P. Dargan, D. Wood, 2020, British journal of clinical pharmacology.

Medical Toxicology and COVID-19: Our Role in a Pandemic

D. Wood, P. Chai, M. Mycyk, 2020, Journal of Medical Toxicology.

Non‐medical use of benzodiazepines and GABA analogues in Europe

Colleen M Haynes, P. Dargan, R. Dart, 2020, British journal of clinical pharmacology.

An evaluation of online discussion relating to nonmedical use of prescription opioids within the UK

P. Dargan, R. Dart, J. Hockenhull, 2020, British Journal of Clinical Pharmacology.

Paracetamol toxicity in mild overdose in combination with opioids: A retrospective observational study

P. Dargan, S. Greene, D. Wood, 2021, British journal of clinical pharmacology.

Prescription opioid abuse in the UK.

P. Dargan, R. Dart, D. Wood, 2013, British journal of clinical pharmacology.

Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data

P. Dargan, D. Wood, C. Yates, 2018, European Journal of Clinical Pharmacology.

Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study

P. Dargan, I. Gawarammana, S. Greene, 2007, Intensive Care Medicine.

Using poisons information service data to assess the acute harms associated with novel psychoactive substances.

P. Dargan, S. H. Thomas, D. Wood, 2014, Drug testing and analysis.

Using Journal Review Articles to Increase the Dissemination of Keynote and Symposia Lectures at International Medical Congresses

P. Dargan, D. Wood, 2012, Journal of Medical Toxicology.

Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation

P. Dargan, W. Waring, D. Wood, 2012, Clinical toxicology.

Chapter 9 – Mephedrone

P. Dargan, D. Wood, D. Wood, 2013 .

Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).

P. Dargan, A. Brailsford, D. Wood, 2011, Drug testing and analysis.

Quantification of cocaine and cocaine metabolites in dried blood spots from a controlled administration study using liquid chromatography-tandem mass spectrometry.

P. Dargan, C. Stove, M. Parkin, 2018, Drug testing and analysis.

Outcomes from massive paracetamol overdose: a retrospective observational study

P. Dargan, S. Greene, D. Wood, 2017, British journal of clinical pharmacology.

Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation

P. Dargan, D. Wood, A. Jones, 2008, Clinical toxicology.

in humans P metabolite kinetics during high-intensity exercise 31 and intramuscular 2 Effects of dichloroacetate on V?o

S. Ward, G. Kemp, F. Howe, 2015 .

Variability in the plasma protein binding of velnacrine (1-hydroxy tacrine hydrochloride) A potential agent for Alzheimer’s disease

J. Ford, D. Wood, C. Roberts, 1996, European Journal of Clinical Pharmacology.

Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015

P. Dargan, C. Stove, S. Hudson, 2017, Clinical toxicology.

Novel Psychoactive Substances: How to Understand the Acute Toxicity Associated With the Use of These Substances

P. Dargan, D. Wood, D. Wood, 2012, Therapeutic Drug Monitoring.

MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance

P. Dargan, M. Haden, D. Wood, 2017, Substance use & misuse.

Perceived risk of using novel psychoactive substances in school students: lower in users compared to non-users

P. Dargan, N. Newton, D. Wood, 2016 .

Current European data collection on emergency department presentations with acute recreational drug toxicity: Gaps and national variations

P. Dargan, D. Wood, C. Yates, 2014, Clinical toxicology.

Acute Toxicity Associated with Analytically Confirmed Recreational use of Methiopropamine (1-(thiophen-2-yl)-2-methylaminopropane)

P. Dargan, S. Hudson, D. Wood, 2014, Journal of Medical Toxicology.

Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity

P. Dargan, S. Greene, D. Wood, 2013, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine

P. Dargan, D. Wood, A. Johnston, 2012, European Journal of Clinical Pharmacology.

ICD-10 coding: poor identification of recreational drug presentations to a large emergency department

P. Dargan, D. Wood, Pamela Conran, 2010, Emergency Medicine Journal.

Detecting novel and emerging recreational drugs on the 'club scene'

J. Ramsey, P. Dargan, D. Wood, 2008 .

Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.

Ò. Miró, P. Dargan, M. Liechti, 2017, Toxicology letters.